好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Interdisciplinary Models of Care Across the Parkinson’s Foundation Designated U.S. Centers: A Survey of Current Practices
Movement Disorders
P7 - Poster Session 7 (5:00 PM-6:00 PM)
5-025

To explore the current landscape of interdisciplinary care across U.S. Centers in the Parkinson’s Foundation Global Care Network (PF-GCN).

The PF-GCN comprises 64 medical centers (50 in the U.S.) meeting strict criteria for excellence in caring for patients with Parkinson’s disease. Many centers feature an interdisciplinary clinic (IDC) model to provide holistic, streamlined care for patients across specialties. This is the first comparative study of U.S. IDCs across the PF-GCN.

We surveyed 50 U.S. PF-GCN designated Centers in August 2024 regarding details of their IDC practices.

Responses were received from 48/50 Centers. Of these, 31 offer an IDC. Most IDC teams included movement disorders neurologists and fellows, physical and occupational therapists, speech pathologists, and social workers, with 21 other specialties represented. Teams ranged from 3-18 providers (median = 8) and the most common time spent per provider was 30 minutes (60% of IDCs, range = 15-90 minutes). Twelve of the 31 IDCs met monthly (range = daily to once every two months) and the median length of an IDC visit was 3 hours (range = 45 minutes to 11 hours). A median of 4 patients (range = 2-39) were seen per IDC day. 

The most common reasons for IDC referral were complexity of care (93% of respondents),  new/increased falls (80%), decreased quality of life (73%), and care partner distress (63%). Most clinics (79.3%) reported a referral timeframe of 3 months or less. Most clinics reported insurance billing as a source of funding (55.2%), followed by philanthropy (20.7%) and PF grants (13.8%).

The majority of U.S. Centers in the PF-GCN offer an IDC, however heterogeneity exists with respect to the specialties represented, funding sources, and various clinic metrics. Clinics reported positive patient and provider experiences and increased efficiency as benefits. Future directions include exploring how different models correlate with patient outcomes.

Authors/Disclosures
Victor D. Armengol, MD
PRESENTER
Dr. Armengol has nothing to disclose.
Kristin Wallock, OTD (PARKINSONS FOUNDATION) Mrs. Wallock has nothing to disclose.
Farren Briggs, PhD (University of Miami Miller School of Medicine) The institution of Prof. Briggs has received research support from NIH.
Mary C. Murray, MPH Mrs. Murray has received personal compensation for serving as an employee of Parkinson's Foundation.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.